相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Guo-Qing Chen et al.
CELL DEATH AND DIFFERENTIATION (2020)
DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin
Jing Du et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
A Temporizing Solution to Artemisinin Resistance
Jigang Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Artemisinin-(Iso)quinoline Hybrids by C-H Activation and Click Chemistry: Combating Multidrug-Resistant Malaria
Aysun Capci et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Interactions between artemisinin derivatives and P-glycoprotein
Yulin Wang et al.
PHYTOMEDICINE (2019)
Iron and leukemia: new insights for future treatments
Fang Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Development of artemisinin resistance in malaria therapy
Janine Nass et al.
PHARMACOLOGICAL RESEARCH (2019)
Artemisinin and its derivatives: a potential treatment for leukemia
Nelson Siukei Lam et al.
ANTI-CANCER DRUGS (2019)
Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
Jigang Wang et al.
ENGINEERING (2019)
Role of CD71 in acute leukemia- An immunophenotypic marker for erythroid lineage or proliferation?
Seema Acharya et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2019)
Beyond malaria: The inhibition of viruses by artemisinin-type compounds
Thomas Efferth
BIOTECHNOLOGY ADVANCES (2018)
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
John F. Deeken et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities
Ning Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Artesunate shows potent anti-tumor activity in B-cell lymphoma
Thea Kristin Vatsveen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds
Lisa Gruber et al.
MOLECULES (2018)
The activity of Artemisia spp. and their constituents against Trypanosomiasis
Janine Nass et al.
PHYTOMEDICINE (2018)
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
Mi Deng et al.
NATURE (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells
Mei Tan et al.
LEUKEMIA RESEARCH (2017)
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia
Bijender Kumar et al.
LEUKEMIA RESEARCH (2017)
Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib
Thomas Efferth
PHYTOMEDICINE (2017)
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Thomas Efferth
SEMINARS IN CANCER BIOLOGY (2017)
m Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia
Amit Budhraja et al.
CLINICAL CANCER RESEARCH (2017)
Cancer combination therapies with artemisinin-type drugs
Thomas Efferth
BIOCHEMICAL PHARMACOLOGY (2017)
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)
Cornelia von Hagens et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Artemisinins enhanced the antileukemic efficacy of BCL2 inhibitors
Blake S. Moses et al.
CANCER RESEARCH (2017)
Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells
Antonios S. Letis et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
An update of current treatments for adult acute myeloid leukemia
Herve Dombret et al.
BLOOD (2016)
Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)
Youyou Tu
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Evaluation of artemisinins for the treatment of acute myeloid leukemia
Christina D. Drenberg et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity
Rashmi Gaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents
Tony Frohlich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?
Zhe Li et al.
MOLECULES (2016)
Antischistosomal activity of artemisinin derivatives in vivo and in patients
Mohamed E. M. Saeed et al.
PHARMACOLOGICAL RESEARCH (2016)
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs
Jennifer M. Fox et al.
ONCOTARGET (2016)
Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities
Christoph Reiter et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids
Christoph Reiter et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia
Bing Xia et al.
LEUKEMIA RESEARCH (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dihydroartemisinin and its derivative induce apoptosis in acute myeloid leukemia through Noxa-mediated pathway requiring iron and endoperoxide moiety
Xuan Zhao et al.
ONCOTARGET (2015)
Role of Microenvironment in Resistance to Therapy in AML
Yoko Tabe et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2015)
A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
Sanjeev Krishna et al.
EBIOMEDICINE (2015)
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer
Therese Ericsson et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells
Christoph Reiter et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
A Screening-Based Approach to Circumvent Tumor Microenvironment-Driven Intrinsic Resistance to BCR-ABL plus Inhibitors in Ph plus Acute Lymphoblastic Leukemia
Harpreet Singh et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum
Tolga Eichhorn et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: A structure-activity study
Bryan T. Mott et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Development of artemisinin compounds for cancer treatment
Henry C. Lai et al.
INVESTIGATIONAL NEW DRUGS (2013)
Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors
Mahadeo A. Sukhai et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Qinghaosu (artemisinin): Chemistry and pharmacology
Ying Li
ACTA PHARMACOLOGICA SINICA (2012)
New artesunic acid homodimers: Potent reversal agents of multidrug resistance in leukemia cells
Christoph Reiter et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
Nicola Goekbuget et al.
BLOOD (2012)
Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
Ning Gao et al.
APOPTOSIS (2011)
Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production
Anne Hamacher-Brady et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
Shahid Soomro et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
Youyou Tu
NATURE MEDICINE (2011)
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion
Nectarios Klonis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
Hao Chen et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Cytotoxicity of Artesunic Acid Homo- and Heterodimer Molecules toward Sensitive and Multidrug-Resistant CCRF-CEM Leukemia Cells
Cindy Horwedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Rene Handrick et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
Serkan Sertel et al.
MOLECULES (2010)
Flavonoids from Artemisia annua L. as Antioxidants and Their Potential Synergism with Artemisinin against Malaria and Cancer
Jorge F. S. Ferreira et al.
MOLECULES (2010)
Drug resistance in mutant FLT3-positive AML
E. Weisberg et al.
ONCOGENE (2010)
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity
Ahmed M. Galal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells
Xuelin Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Anticancer activities of artemisinin and its bioactive derivatives
Gary L. Firestone et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction
Luke H. Stockwin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression
Hui-Jun Zhou et al.
ANTI-CANCER DRUGS (2008)
Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species
Jin-Jian Lu et al.
CANCER BIOLOGY & THERAPY (2008)
Artesunate derived from traditional Chinese medicine induces DNA damage and repair
Paul C. H. Li et al.
CANCER RESEARCH (2008)
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
Ikuhiko Nakase et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate
Gerhard Kelter et al.
PLOS ONE (2007)
Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
Thomas Efferth et al.
PLOS ONE (2007)
Multiple molecular mechanisms for multidrug resistance transporters
Christopher F. Higgins
NATURE (2007)
Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds
Amy E. Mercer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics:: are we ready for a prognostically prioritized molecular classification?
Krzysztof Mrozek et al.
BLOOD (2007)
Anticancer activity of artemisinin-derived trioxanes
Gary H. Posner et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins
L. Anfosso et al.
PHARMACOGENOMICS JOURNAL (2006)
Modeling the decomposition mechanism of artemisinin
Pamela Moles et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2006)
Mechanisms and strategies to overcome multiple drug resistance in cancer
Tomris Ozben
FEBS LETTERS (2006)
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
T Efferth
CURRENT DRUG TARGETS (2006)
Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds
H Lai et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
T Efferth
DRUG RESISTANCE UPDATES (2005)
Combination-treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
T Efferth et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Control of Bcl-2 expression by reactive oxygen species
DA Hildeman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hybrid systems through natural product leads: An approach towards new molecular entities
G Mehta et al.
CHEMICAL SOCIETY REVIEWS (2002)
Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells
T Efferth et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
New chemical and biological aspects of artemisinin-derived trioxane dimers
GH Posner et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs
A Robert et al.
ACCOUNTS OF CHEMICAL RESEARCH (2002)
分享论文
